Trial in progress: A phase 2, single-arm, open-label study of itacitinib (ITA) for the prevention of chimeric antigen receptor (CAR) T-cell-induced cytokine release syndrome (CRS) Meeting Abstract


Authors: Park, J. H.; Frigault, M. J.; Maziarz, R. T.; Nairn, A.; Burke, L.; Tian, C.; Porters, D. L.
Abstract Title: Trial in progress: A phase 2, single-arm, open-label study of itacitinib (ITA) for the prevention of chimeric antigen receptor (CAR) T-cell-induced cytokine release syndrome (CRS)
Meeting Title: Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 26
Issue: 3 Suppl.
Meeting Dates: 2020 Feb 19-23
Meeting Location: Orlando, FL
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2020-03-01
Start Page: S269
Language: English
ACCESSION: WOS:000516887900404
PROVIDER: wos
DOI: 10.1016/j.bbmt.2019.12.436
Notes: Meeting Abstract 405 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Jae Hong Park
    178 Park